India Biosimilar Cetuximab Go-Ahead: Merck KGaA Wants Data In Public Domain

 
• By Anju Ghangurde
Merck seeks biosimilar cetuximab data be placed in the public domain • Source: Shutterstock

More from India

More from Focus On Asia